The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns for metastatic melanoma in US community oncology clinical practice: A retrospective observational study.
 
Eric D. Whitman
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Castle Biosciences; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme
Research Funding - Amgen; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - Atlantic Melanoma Center (Inst)
 
Frank Xiaoqing Liu
Employment - Baxter; Merck Sharp & Dohme
Stock and Other Ownership Interests - Baxter
Research Funding - Baxter; Merck Sharp & Dohme
 
Xiting Cao
Employment - Merck Sharp & Dohme
 
Amin Haiderali
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Amy Pickar Abernethy
Employment - Flatiron Health
Leadership - Athenahealth
Stock and Other Ownership Interests - AthenaHealth; Flatiron Health; Orange Leaf Associates
Consulting or Advisory Role - Bristol-Myers Squibb; Helsinn Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); DARA BioSciences (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Pfizer (Inst)